QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
Log in
OTCMKTS:VEGPF

Vectura Group Stock Forecast, Price & News

$1.32
-0.05 (-3.97 %)
(As of 10/20/2020 10:02 AM ET)
Add
Compare
Today's Range
$1.32
Now: $1.32▼
$1.32
50-Day Range
$1.37
MA: $1.43▼
$1.48
52-Week Range
$0.80
Now: $1.32▼
$1.48
Volume200 shs
Average Volume8,686 shs
Market Capitalization$794.96 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta and Anoro Ellipta for the treatment of COPD. Its generic partnering products include flutiform, VR315, VR506, VR730, VR632, VR2081, VR410, and Ellipta for the treatment of asthma; and Phase I clinical stage product is the VR475 (US) for the treatment of severe adult asthma. The company's Phase II clinical stage products comprise VR465 for treating respiratory syncytial virus infection; VR647 for the treatment of paediatric asthma; and VR736 for the treatment severe influenza. Its Phase III clinical stage products include QVM149 for the treatment of asthma; and VR475 (EU) for the treatment of severe adult asthma. The company also provides dry powder inhalers; pressurized meter dose inhalers; and smart nebulizers. Vectura Group plc was founded in 1997 and is headquartered in Chippenham, the United Kingdom.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.46 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:VEGPF
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.vectura.com
Phone44-0-12-4966-7700
Employees478

Debt

Debt-to-Equity Ratio0.02
Current Ratio2.28
Quick Ratio1.85

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$227.68 million
Price / Sales3.49
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.89 per share
Price / Book1.48

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares604,260,000
Market Cap$794.96 million
Next Earnings DateN/A
OptionableNot Optionable
$1.32
-0.05 (-3.97 %)
(As of 10/20/2020 10:02 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VEGPF News and Ratings via Email

Sign-up to receive the latest news and ratings for VEGPF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Vectura Group (OTCMKTS:VEGPF) Frequently Asked Questions

How has Vectura Group's stock price been impacted by Coronavirus (COVID-19)?

Vectura Group's stock was trading at $1.12 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, VEGPF stock has increased by 17.5% and is now trading at $1.3156.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Vectura Group?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vectura Group in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Vectura Group.

Who are some of Vectura Group's key competitors?

Some companies that are related to Vectura Group include Nektar Therapeutics (NKTR), GW Pharmaceuticals PLC- (GWPH), Opko Health (OPK), Eidos Therapeutics (EIDX), Alkermes (ALKS), Axsome Therapeutics (AXSM), Apellis Pharmaceuticals (APLS), Agios Pharmaceuticals (AGIO), Harmony Biosciences (HRMY), Seres Therapeutics (MCRB), I-Mab (IMAB), Xencor (XNCR), Taro Pharmaceutical Industries (TARO), Pacira Biosciences (PCRX) and Aimmune Therapeutics (AIMT).
View all competitors.

Who are Vectura Group's key executives?

Vectura Group's management team includes the following people:
  • Mr. James Ward-Lilley, CEO & Exec. Director (Age 54)
  • Mr. Paul Fry, CFO & Exec. Director
  • Mr. Anthony Fitzpatrick, Exec. VP of Operations
  • Elizabeth Knowles, VP of Investor Relations
  • Mr. John Murphy, Gen. Counsel & Company Sec. (Age 66)

What is Vectura Group's stock symbol?

Vectura Group trades on the OTCMKTS under the ticker symbol "VEGPF."

How do I buy shares of Vectura Group?

Shares of VEGPF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vectura Group's stock price today?

One share of VEGPF stock can currently be purchased for approximately $1.32.

How big of a company is Vectura Group?

Vectura Group has a market capitalization of $794.96 million and generates $227.68 million in revenue each year. The company earns $-28,220,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. Vectura Group employs 478 workers across the globe.

What is Vectura Group's official website?

The official website for Vectura Group is www.vectura.com.

How can I contact Vectura Group?

Vectura Group's mailing address is One Prospect West, Wiltshire X0, SN14 6FH. The company can be reached via phone at 44-0-12-4966-7700 or via email at [email protected]

This page was last updated on 10/20/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.